Bhanu Prasad Kommineni

Bhanu Prasad Kommineni

Active Director Director DIN 01408377
DIN 01408377 First appointment May 2007 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Total affiliations 3 Since May 2007
Shareholding value •••• Premium profile

About Bhanu Prasad Kommineni

Data last updated:

Bhanu Prasad Kommineni is a Director at Apogen Remedies Private Limited (since 2011), Director at Ur Advanced Therapeutics Private Limited (since 2023) and Director at Bhan Pharmainfo Private Limited (since 2007). The companies operate in Pharma and Service. The 3 current companies with reported revenue have a combined latest revenue of ₹9.34 Cr; the largest is Apogen Remedies Private Limited at ₹8.63 Cr (FY 2025).

DIN 01408377
Primary Designation Director
Industry Pharma
First Appointment 18 May 2007
Oldest Company Age 19 yrs
Largest company Apogen Remedies Private Limited · ₹8.63 Cr (FY 2025)
Combined revenue ₹9.34 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Apogen Remedies Private Limited U24232TG2011PTC075363
Director05 Jul 20112011₹8.63 Cr (FY 2025)Active
Director16 Dec 20232020₹56.9 Lakh (FY 2025)Active
Bhan Pharmainfo Private Limited U24232TG2007PTC054050
Director18 May 20072007₹13.6 Lakh (FY 2025)Active

Directorship timeline

Open interactive timeline →
Bhan Pharmainfo Private Limited
Apogen Remedies Private Limited
Ur Advanced Therapeutics Private Limited
Premium access

Shareholding and investment profile for Bhanu Prasad Kommineni

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bhanu Prasad Kommineni

Bhanu Prasad Kommineni currently holds 3 directorships: Apogen Remedies Private Limited (Director, since 05 Jul 2011, revenue ₹8.63 Cr (FY 2025)); Ur Advanced Therapeutics Private Limited (Director, since 16 Dec 2023, revenue ₹56.9 Lakh (FY 2025)); Bhan Pharmainfo Private Limited (Director, since 18 May 2007, revenue ₹13.6 Lakh (FY 2025)).

Bhanu Prasad Kommineni was first appointed on 18 May 2007 as Director at Bhan Pharmainfo Private Limited. The most recent appointment on record is 16 Dec 2023 at Ur Advanced Therapeutics Private Limited.

The 3 current companies of Bhanu Prasad Kommineni that report revenue have a combined latest revenue of ₹9.34 Cr: Apogen Remedies Private Limited ₹8.63 Cr (FY 2025); Ur Advanced Therapeutics Private Limited ₹56.9 Lakh (FY 2025); Bhan Pharmainfo Private Limited ₹13.6 Lakh (FY 2025).

The current boards of Bhanu Prasad Kommineni's companies include Abhishek Shukla (Apogen Remedies Private Limited), Bala Murali Krishna Thippabhotla (Apogen Remedies Private Limited), Tamma Raghava Srinivasa Reddy (Apogen Remedies Private Limited), Vikram Bery (Apogen Remedies Private Limited), Aparna Rachamallu (Ur Advanced Therapeutics Private Limited), Jangamreddy Jagan Mohan Reddy (Ur Advanced Therapeutics Private Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available